Nektar Therapeutics (NKTR) is near the bottom in its sector according to InvestorsObserver.
NKTR gets an overall rating of 15. That means it scores higher than 15% of stocks.
Nektar Therapeutics gets a 28 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.
NKTR has an Overall Score of 15. Find out what this means to you and get the rest of the rankings on NKTR!
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.
The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Nektar Therapeutics Stock Today?
Nektar Therapeutics (NKTR) stock is trading at $18.25 as of 11:43 AM on Friday, Sep 24, a drop of -$0.21, or -1.14% from the previous closing price of $18.46. The stock has traded between $18.01 and $18.67 so far today. Volume today is below average. So far 309,936 shares have traded compared to average volume of 898,313 shares.
Click Here to get the full Stock Report for Nektar Therapeutics stock.